27 related articles for article (PubMed ID: 3840886)
1. Expanding PHM Fellowships: Current Landscape, Challenges, and Potential Solutions.
Fuchs J; Rajbhandari P; Webb N; Walker J
Hosp Pediatr; 2024 Feb; 14(2):e116-e119. PubMed ID: 38282530
[No Abstract] [Full Text] [Related]
2. Confidentiality and the VIP.
Oldham JM
J Psychiatr Pract; 2023 Nov; 29(6):429. PubMed ID: 37948167
[No Abstract] [Full Text] [Related]
3. Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.
Linder S; Barkhem T; Norberg A; Persson H; Schalling M; Hökfelt T; Magnusson G
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):605-9. PubMed ID: 3025882
[TBL] [Abstract][Full Text] [Related]
4. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors.
Fahrenkrug J; Pedersen JH
Peptides; 1986; 7(5):717-21. PubMed ID: 3797338
[TBL] [Abstract][Full Text] [Related]
5. Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells.
Hoshino M; Yanaihara C; Ogino K; Iguchi K; Sato H; Suzuki T; Yanaihara N
Peptides; 1984; 5(2):155-60. PubMed ID: 6548020
[TBL] [Abstract][Full Text] [Related]
6. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain.
Fahrenkrug J; Emson PC
J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258
[TBL] [Abstract][Full Text] [Related]
7. Gene expression and transcript size of the prepro-peptide VIP/PHM-27 in normal human tissue.
Schulte-Bockholt A; Meier DA; Hopp K; Stadelmann A; Otterson MF; Telford GL; Koch TR
Neurosci Lett; 1993 Dec; 164(1-2):101-4. PubMed ID: 8152582
[TBL] [Abstract][Full Text] [Related]
8. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
9. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
Fahrenkrug J
Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
[TBL] [Abstract][Full Text] [Related]
10. The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.
Rosselin G
Peptides; 1986; 7 Suppl 1():89-100. PubMed ID: 3018707
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis and Function of VIP and Oxytocin: Mechanisms of C-terminal Amidation, Oxytocin Secretion and Transport.
Yonekura H; Kato I; Yamamoto Y; Ikeda T; Higashida H; Okamoto H
Endocrinology; 2023 Aug; 164(9):. PubMed ID: 37548257
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide and anterior pituitary function.
Prysor-Jones RA; Jenkins JS
Clin Endocrinol (Oxf); 1988 Dec; 29(6):677-88. PubMed ID: 3076850
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
